Lifecore Biomedical Inc Watch

EX-10.3

from 8-K 7 pages Separation Agreement and General Release

12/34/56

EX-10.2

from 8-K 17 pages Lifecore Biomedical, Inc. Equity Inducement Plan Effective Date March 20, 2024

12/34/56

EX-10.1

from 8-K 6 pages Material contract

12/34/56

EX-10.32

from 10-K 12 pages Material contract

12/34/56

EX-10.31

from 10-K 13 pages Material contract

12/34/56

EX-10.30

from 10-K 12 pages Material contract

12/34/56

EX-10.4

from 8-K 5 pages Material contract

12/34/56

EX-10.3

from 8-K 27 pages Material contract

12/34/56

EX-10.2

from 8-K 11 pages Material contract

12/34/56

EX-10.1

from 8-K 8 pages Material contract

12/34/56

EX-10.6

from 8-K 17 pages Amended and Restated Supply Agreement

12/34/56

EX-10.5

from 8-K 15 pages Equipment Lease Agreement

12/34/56

EX-10.4

from 8-K 9 pages Equipment Sale and Leaseback Agreement

12/34/56

EX-10.2

from 8-K 37 pages Pledge and Security Agreement Dated as of May 22, 2023 by and Among Each of the Grantors Party Hereto and Alcon Research, LLC, as Collateral Agent

12/34/56

EX-10.1

from 8-K 133 pages Recitals

12/34/56

EX-10.1

from 8-K 1 page Amendment Dated April 27, 2023 to the Lifecore Biomedical, Inc. (F/K/a Landec Corporation) Executive Change in Control Severance Plan

12/34/56

EX-10.4

from 8-K 127 pages Material contract

12/34/56

EX-10.3

from 8-K 110 pages Material contract

12/34/56

EX-10.2

from 8-K 33 pages Material contract

12/34/56

EX-10.1

from 8-K 40 pages Material contract

12/34/56